We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
(-25%)
Cap. Flow
-$5.59B
Cap. Flow
% of AUM
-19.76%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$97.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$95.6M |
| 3 |
Cheniere Energy
LNG
|
+$94.4M |
| 4 |
Visa
V
|
+$92.5M |
| 5 |
AstraZeneca
AZN
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$204M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
NVIDIA
NVDA
|
+$131M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$130M |
| 5 |
Marathon Petroleum
MPC
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 13.09% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
401
Permian Resources
PR
$17.6B
| $6.58M | 0.02% |
1,101,135
+255,600
| +30% | +$2.04M |
|
402
Protolabs
PRLB
$1.79B
| $6.51M | 0.02% |
136,009
+61,532
| +83% | +$2.85M |
|
403
Lulu's Fashion Lounge
LVLU
$47.9M
| $6.48M | 0.02% |
+39,797
| New | +$7.03M |
|
404
Byline Bancorp
BY
$1.78B
| $6.29M | 0.02% |
264,300
-29,933
| -10% | -$723K |
|
405
Moody's
MCO
$83.5B
| $6.1M | 0.02% |
22,445
+3,125
| +16% | +$935K |
|
406
Syndax Pharmaceuticals
SNDX
$1.73B
| $6.06M | 0.02% |
314,914
+21,565
| +7% | +$359K |
|
407
Roku
ROKU
$21.5B
| $6.03M | 0.02% |
73,446
+4,007
| +6% | +$388K |
|
408
Stanley Black & Decker
SWK
$14.9B
| $6.01M | 0.02% |
57,327
-94,107
| -62% | -$11.6M |
|
409
Distribution Solutions Group
DSGR
$1.6B
| $5.97M | 0.02% |
232,336
+15,802
| +7% | +$329K |
|
410
McCormick & Company Non-Voting
MKC
$13.7B
| $5.94M | 0.02% |
71,366
-20,360
| -22% | -$1.93M |
|
411
Ollie's Bargain Outlet
OLLI
$4.4B
| $5.88M | 0.02% |
+100,000
| New | +$5.06M |
|
412
Rimini Street
RMNI
$454M
| $5.87M | 0.02% |
976,152
+69,600
| +8% | +$414K |
|
413
Manhattan Associates
MANH
$11.1B
| $5.73M | 0.02% |
+50,000
| New | +$6.23M |
|
414
Smartbird Inc
BIRD
$20.3M
| $5.71M | 0.02% |
72,627
-72,507
| -50% | -$7.32M |
|
415
Five Below
FIVE
$12.1B
| $5.68M | 0.02% |
50,078
-11,677
| -19% | -$1.68M |
|
|
ONT
416
Onterris Inc
ONT
$731M
| $5.66M | 0.02% |
167,504
+11,372
| +7% | +$476K |
|
417
Forrester Research
FORR
$189M
| $5.62M | 0.02% |
+117,520
| New | +$6.09M |
|
418
Talos Energy
TALO
$2.44B
| $5.57M | 0.02% |
+359,729
| New | +$7M |
|
419
NXP Semiconductors
NXPI
$61.8B
| $5.39M | 0.02% |
36,446
-7,441
| -17% | -$1.29M |
|
420
AudioCodes
AUDC
$235M
| $5.34M | 0.02% |
242,129
-836
| -0.3% | -$19.2K |
|
|
USER
421
DELISTED
UserTesting, Inc.
USER
| $5.24M | 0.02% |
1,044,156
+70,889
| +7% | +$476K |
|
422
Golar LNG
GLNG
$4.91B
| $5.22M | 0.02% |
+229,348
| New | +$5.48M |
|
423
CRISPR Therapeutics
CRSP
$4.77B
| $5.2M | 0.02% |
+85,549
| New | +$5.03M |
|
424
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| $5.15M | 0.02% |
160,952
+3,306
| +2% | +$136K |
|
425
Willdan Group
WLDN
$1.06B
| $5.11M | 0.02% |
185,132
-98,978
| -35% | -$2.71M |
|
Similar funds
Lord, Abbett & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.
- Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
- Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
- Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
- Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
- Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
- Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.
Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.